• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Credit Suisse Lux Biotechnology Equity Fund

+ Add to Watchlist

CLABIOT:LX

385.66 USD 10.72 2.86%

As of 00:59:30 ET on 10/23/2014.

Snapshot for Credit Suisse Lux Biotechnology Equity Fund (CLABIOT)

Year To Date: +21.61% 3-Month: +11.37% 3-Year: +40.07% 52-Week Range: 277.05 - 385.66
1-Month: +4.21% 1-Year: +30.28% 5-Year: +25.84% Beta vs NBI: 1.01

Mutual Fund Chart for CLABIOT

No chart data available.
  • CLABIOT:LX 385.66
  • 1M
  • 1Y
Interactive CLABIOT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CLABIOT

Credit Suisse Lux Biotechnology Equity Fund is a SICAV incorporated in Luxembourg. The Fund is actively managed aiming to outperform the return of the NASDAQ Biotechnology TR benchmark. The Fund mainly invests in equity and equity-type securities of issuers engaged in the biotechnology industry.

Inception Date: 11-06-2001 Telephone: -
Managers: IRENE BEATRICE PUETTNER
Web Site: www.credit-suisse.com

Fundamentals for CLABIOT

NAV (on 2014-10-23) 385.66
Assets (M) (on 2014-10-23) 208.93
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 100.00

Dividends for CLABIOT

No dividends reported

Fees & Expenses for CLABIOT

Front Load 3.00
Back Load 0.00
Current Mgmt Fee 2.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for CLABIOT

Filing Date: 07/31/2014
Name Position Value % of Total
Gilead Sciences Inc 185,484 16,981,060 8.907%
Celgene Corp 180,276 15,711,053 8.241%
Biogen Idec Inc 42,745 14,293,501 7.497%
Amgen Inc 111,973 14,264,240 7.482%
Alexion Pharmaceuticals Inc 61,752 9,817,950 5.150%
Regeneron Pharmaceuticals Inc 28,000 8,854,160 4.644%
Vertex Pharmaceuticals Inc 94,000 8,357,540 4.384%
BioMarin Pharmaceutical Inc 114,444 7,074,928 3.711%
Incyte Corp 125,000 5,946,250 3.119%
Medivation Inc 80,000 5,938,400 3.115%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil